BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)

BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

GlobeNewsWire • Oct 20, 2026

Top 3 Health Care Stocks That May Fall Off A Cliff In October

As of Oct. 16, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Oct 16, 2026

OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKesson

MONSEY, N.Y., Oct. 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Option Care Health, Inc. (NASDAQ: OPCH) (“OPCH”) to CD&R and McKesson Corporation for $32.05 per share in cash.

GlobeNewsWire • Oct 13, 2026

OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $OPCH--OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law.

Business Wire • Oct 12, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Option Care Health, Inc. (NASDAQ: OPCH)

NEW YORK, Oct. 11, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Option Care Health, Inc. (NASDAQ: OPCH ) related to its sale to an investor group comprised of affiliates of Clayton, Dubilier & Rice, LLC and McKesson Corporation.

PRNewsWire • Oct 11, 2026

Option Care Health Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Option Care Health, Inc. - OPCH

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Option Care Health, Inc. (NasdaqGS: OPCH) to CD&R, McKesson Corporation. Under the terms of the proposed transaction, shareholders of Option Care will receive $32.05 in cash for each share of Option Care that they own. KSF is seeking to determine whether this consideration and the process t.

Business Wire • Oct 8, 2026

This Option Care Health Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga • Oct 7, 2026

Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?

Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Oct 7, 2026

Why Option Care Health Stock Skyrocketed on Tuesday

Option Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice. The deal values Option Care at $32.05 per share or about $5.8 billion.

The Motley Fool • Oct 6, 2026

OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.

Option Care Health shareholders will receive just $32.05 per share, representing a total enterprise value of approximately $5.8 billion; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 6, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Option Care Health (NASDAQ: OPCH) by CD&R and McKesson Corporation, provides fair value to Option Care Health's public shareholders and whether Option Care Health's Board adequately protected shareholder interests in negotiating and approving the transaction. Are You a Option Care Health Shareholder?

PRNewsWire • Oct 7, 2026